Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Srabanti Jana"'
Publikováno v:
Future Medicinal Chemistry. 15:189-210
Aim: Multitargeted drugs are essential for the treatment of various neurodegenerative disorders, because of their complex nature. This study aimed to develop novel small molecules as selective monoamine oxidase B (MAO-B) inhibitors with cholinesteras
Publikováno v:
Future Medicinal Chemistry. 12:1037-1069
Cancer, characterized by uncontrolled malignant neoplasm, is a leading cause of death in both advanced and emerging countries. Although, ample drugs are accessible in the market to intervene with tumor progression, none are totally effective and safe
Autor:
Ankit Ganeshpurkar, Dileep Kumar, Sushil Kumar Singh, Ravi Shankar Singh, Sukesh Kumar Gupta, Devendra Kumar, Sairam Krishnamurthy, Srabanti Jana, Rayala Swetha, Gopichand Gutti
Publikováno v:
Future Medicinal Chemistry. 11:3161-3178
Aim: A breakthrough in modern medicine, in terms of treatment of Alzheimer’s disease, is yet to be seen, as the scene is currently plagued with numerous clinical trial failures. Here, we are exploring multifunctional hybrid sulfonamides for their a
Autor:
Devendra Kumar, Ashok Kumar, Srabanti Jana, Ravi Shankar Singh, Dileep Kumar, Sushil Kumar Singh, Ankit Ganeshpurkar, Rayala Swetha, Gopichand Gutti, Gore P Gangaram
Publikováno v:
Current Topics in Medicinal Chemistry. 19:501-533
Background:Alzheimer’s Disease (AD), a multifaceted disorder, involves complex pathophysiology and plethora of protein-protein interactions. Thus such interactions can be exploited to develop anti-AD drugs.Objective:The interaction of dynamin-relat
Autor:
Sushil Kumar Singh, Srabanti Jana
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 37:944-965
Matrix metalloproteinase-9 (MMP-9) is a significant target for the development of drugs for the treatment of arthritis, CNS disorders, and cancer metastasis. The structure-based and ligand-based methods were used for the virtual screening (VS) of dat
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 225:112351
This work demonstrates binding interactions of two cationic gemini surfactants, 12-4-12,2Br− and 12-8-12,2Br− with gold nanoparticles (AuNPs)-conjugated bovine serum albumin (BSA) presenting binding isotherms from specific binding to saturation b
Publikováno v:
RSC Advances. 8:39477-39495
Ligand-based and energy-optimized structure-based approaches were considered to obtain excellent candidates as AChE inhibitors. The known AChE inhibitors were utilized to develop a pharmacophore hypothesis, HPRRR and X-ray crystallographic structures
Autor:
Nilanjan Adhikari, Gouri Ahir, Hanan A. Al-Dossary, Meneerah Abdurhman Aljafary, Khulood Mohammed Al-Khater, Ebtesam Abdullah Al-Suhaimi, Sk. Abdul Amin, Ghulam Md Ashraf, Reem A. Assuhaimi, Himani Balutia, Anwar L. Bilgrami, Diana Campos-Iglesias, Sapana Sameer Chaudhary, Sameer Choudhary, V. Cicaloni, Rohit Dutt, Sayan Dutta Gupta, Abdelhamid Elaissari, I. Fotopoulos, José M.P. Freije, Ankit Ganeshpurkar, Vandana Garg, Rishitha Gundala, Satya P. Gupta, Nahor Haddish-Berhane, D. Hadjipavlou-Litina, B.S. Harish, Srabanti Jana, Tarun Jha, Deepak Kumar, Devendra Kumar, Sanjay Kumar, R. Lavanya, Carlos López-Otín, A.K. Madan, Ayesha Mahmood, Subhajit Makar, Tanima Mandal, Ashima Nagpal, Dolly A. Parasrampuria, A. Peperidou, F. Pettini, Nitesh Kumar Poddar, E. Pontiki, Pankaj Kumar Rai, Vijaya Ravinayagam, Sakshi Rawat, Kuldeep K. Roy, Priyanka Saha, Adeeb Shehzad, Devendra Shukla, Sushil Kumar Singh, O. Spiga, Amit Kumar Srivastava, Mohamad Tarhini, Rajiv Kumar Tonk, A. Trezza, Kiran Babu Uppuluri, Ravichandiran Velayutham, Saroj Verma, Alex Yu, Nadiah Zafar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40f3c3d926635f7d60fe2a9c487d48a9
https://doi.org/10.1016/b978-0-12-818168-3.09990-3
https://doi.org/10.1016/b978-0-12-818168-3.09990-3
Cancer is one of the leading causes of death among various noncommunicable diseases. The proteases, involved in tumor progression and metastasis, are the attractive targets for anticancer therapy. This chapter presents a collective view on the struct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fa0da04814f8b8a43d97f81d00f3a20
https://doi.org/10.1016/b978-0-12-818168-3.00005-x
https://doi.org/10.1016/b978-0-12-818168-3.00005-x
Autor:
Sushil Kumar Singh, Srabanti Jana
Tau-tubulin kinase 1 inhibitors inhibit tau protein phosphorylation on Ser198, Ser199, Ser202, Ser422, and also in paired helical filaments. We developed receptor-based pharmacophore models by exploiting three TTBK1 protein structures, i.e., 4NFN, 4B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d520bbcdcdc10b2d0b352a13931e2646